Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: A randomised controlled trial: Thorax 2005;60:480–7.

✍ Scribed by E.F.M. Wouters; D.S. Postma; B. Fokkens; W.C.J. Hop; J. Prins; A.F. Kuipers; H.R. Pasma; C.A.J. Hensing; E.C. Creutzberg

• Book ID: 116873307
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 58 KB
• Volume: 1
• Category: Article
• ISSN: 1745-0454
• DOI: 10.1016/j.rmedu.2005.09.024